Page last updated: 2024-08-25

rosiglitazone and calpain

rosiglitazone has been researched along with calpain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badenhoop, K; Bölck, B; Busse, R; Cohen, RA; Dixit, M; Fleming, I; Pistrosch, F; Randriamboavonjy, V; Schwinger, RH	1

Trials

1 trial(s) available for rosiglitazone and calpain

Article	Year
Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone. Circulation, 2008, Jan-01, Volume: 117, Issue:1 Topics: Adult; Aged; Blood Platelets; Calpain; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Humans; Male; Megakaryocytes; Middle Aged; Nitro Compounds; Platelet Endothelial Cell Adhesion Molecule-1; PPAR gamma; Rosiglitazone; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Thiazolidinediones	2008

Article

Year

Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone.

Circulation, 2008, Jan-01, Volume: 117, Issue:1

Topics: Adult; Aged; Blood Platelets; Calpain; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Humans; Male; Megakaryocytes; Middle Aged; Nitro Compounds; Platelet Endothelial Cell Adhesion Molecule-1; PPAR gamma; Rosiglitazone; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Thiazolidinediones

2008